We are live on ! Find out more
CRDF icon

Cardiff Oncology
CRDF

90 hedge funds and large institutions have $29.1M invested in Cardiff Oncology in 2024 Q2 according to their latest regulatory filings, with 29 funds opening new positions, 33 increasing their positions, 12 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

683% more call options, than puts

Call options by funds: $1.86M | Put options by funds: $238K

175% more repeat investments, than reductions

Existing positions increased: 33 | Existing positions reduced: 12

81% more first-time investments, than exits

New positions opened: 29 | Existing positions closed: 16

17% more funds holding

Funds holding: 77 → 90 (+13)

10.02% more ownership

Funds ownership: 19.25% → 29.26% (+10%)

37% less capital invested

Capital invested by funds: $45.8M → $29.1M (-$16.8M)

Holders
90
Holders Change
+13
Holders Change %
+16.88%
% of All Funds
1.3%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
29
Increased
33
Reduced
12
Closed
16
Calls
$1.86M
Puts
$238K
Net Calls
+$1.63M
Net Calls Change
-$2.71M

Top Buyers

1
BlackRock
BlackRock
New York
+$7.35M
2
Assenagon Asset Management
Assenagon Asset Management
Luxembourg
+$3.63M
3
State Street
State Street
Massachusetts
+$2.51M
4
Geode Capital Management
Geode Capital Management
Massachusetts
+$1.79M
5
Morgan Stanley
Morgan Stanley
New York
+$1.63M

Top Sellers

1
LCM
Laurion Capital Management
New York
-$4.96M
2
Millennium Management
Millennium Management
New York
-$1.67M
3
EI
EAM Investors
California
-$865K
4
Marshall Wace
Marshall Wace
United Kingdom
-$512K
5
Goldman Sachs
Goldman Sachs
New York
-$501K
Name Holding Trade Value Shares
Change 		Change in
Stake
Royal Bank of Canada
51
Royal Bank of Canada
Ontario, Canada
$47K +$22.9K +6,070 +40%
CF
52
Corebridge Financial
Texas
$47K +$79.4K +21,075 New
Dimensional Fund Advisors
53
Dimensional Fund Advisors
Texas
$42.4K +$18.4K +4,892 +34%
Invesco
54
Invesco
Georgia
$40.4K +$68.5K +18,180 New
Squarepoint
55
Squarepoint
New York
$40.1K +$2K +532 +3%
UBV
56
United Bank (Virginia)
Virginia
$40K +$9.42K +2,500 +16%
MTIM
57
Marathon Trading Investment Management
Pennsylvania
$39K +$9.72K +2,580 +17%
GSC
58
Ground Swell Capital
South Carolina
$38K +$64.4K +17,098 New
JP Morgan Chase
59
JP Morgan Chase
New York
$37.1K +$62.9K +16,695 +64,212%
HighTower Advisors
60
HighTower Advisors
Illinois
$36K -$7.41K -1,965 -11%
FWS
61
FinDec Wealth Services
California
$35.5K – – –
DWM
62
Denver Wealth Management
Colorado
$33.8K +$11.3K +3,000 +25%
GIA
63
Gladstone Institutional Advisory
Florida
$33.3K – – –
Wolverine Trading
64
Wolverine Trading
Illinois
$33.3K -$5.56K -1,475 -9%
OQS
65
Occudo Quantitative Strategies
Florida
$32.3K +$54.9K +14,566 New
Barclays
66
Barclays
United Kingdom
$30.1K +$51.1K +13,547 New
PI
67
PFG Investments
New York
$27.8K +$9.42K +2,500 +25%
PD
68
Point72 (DIFC)
United Arab Emirates
$27.3K +$46.3K +12,284 New
AllianceBernstein
69
AllianceBernstein
Tennessee
$23K +$39.1K +10,380 New
TIM
70
Tortoise Investment Management
New York
$22.2K – – –
SNB
71
Security National Bank
Nebraska
$21.7K – – –
Citigroup
72
Citigroup
New York
$19.3K -$280K -74,425 -90%
AFIA
73
America First Investment Advisors
Nebraska
$8.88K – – –
Legal & General Group
74
Legal & General Group
United Kingdom
$8.55K +$14.4K +3,824 New
AIP
75
Ameritas Investment Partners
Nebraska
$8.52K +$14.5K +3,838 New
1 2
3
4 5

CRDF Hedge Fund Activity: Q2 2024 in Review

90 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in Cardiff Oncology (CRDF) for Q2 2024, worth a combined $29.1M — down 37% from $45.8M a quarter earlier.

Buyers outnumbered sellers: 29 funds opened new CRDF positions and 16 closed out — a net gain of 13 holders — while 33 added to existing stakes and 12 trimmed.

The largest buyer was BlackRock, adding an estimated $7.35M. The largest seller was Laurion Capital Management, exiting entirely with an estimated $4.96M sold.

  • 90 institutional investors held Cardiff Oncology (CRDF) as of Q2 2024, up from 77 in Q1 2024.
  • Funds reported $29.1M of Cardiff Oncology stock for Q2 2024, down 37% quarter-over-quarter.
  • 29 funds opened new Cardiff Oncology positions in Q2 2024 and 16 closed out, a net change of +13 holders.
  • The largest Cardiff Oncology buyer in Q2 2024 was BlackRock, an estimated $7.35M added.
  • The largest Cardiff Oncology seller in Q2 2024 was Laurion Capital Management, an estimated $4.96M sold.

Based on aggregated 13F filings for Q2 2024.